Zhejiang Orient Gene Biotech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.82%

Zhejiang Orient Gene Biotech Co Ltd (688298) has an Asset Resilience Ratio of 2.82% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang Orient Gene Biotech Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥211.69 Million

≈ $30.98 Million USD Cash + Short-term Investments

Total Assets

CN¥7.51 Billion

≈ $1.10 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Zhejiang Orient Gene Biotech Co Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of Zhejiang Orient Gene Biotech Co Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Orient Gene Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Zhejiang Orient Gene Biotech Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥211.69 Million	2.82%
Total Liquid Assets	CN¥211.69 Million	2.82%

Asset Resilience Insights

Limited Liquidity: Zhejiang Orient Gene Biotech Co Ltd maintains only 2.82% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Orient Gene Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Orient Gene Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	36.63%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Shanghai Kinetic Medical Co SHE:300326	Medical Devices	28.89%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
EBR Systems Inc AU:EBR	Medical Devices	48.75%
Aroa Biosurgery Ltd AU:ARX	Medical Devices	12.13%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%

Annual Asset Resilience Ratio for Zhejiang Orient Gene Biotech Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Orient Gene Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.56%	CN¥207.58 Million ≈ $30.38 Million	CN¥8.09 Billion ≈ $1.18 Billion	-9.13pp
2023-12-31	11.70%	CN¥1.05 Billion ≈ $153.98 Million	CN¥9.00 Billion ≈ $1.32 Billion	+0.85pp
2022-12-31	10.84%	CN¥1.16 Billion ≈ $169.84 Million	CN¥10.70 Billion ≈ $1.57 Billion	+8.97pp
2021-12-31	1.87%	CN¥168.07 Million ≈ $24.59 Million	CN¥8.98 Billion ≈ $1.31 Billion	-3.70pp
2020-12-31	5.57%	CN¥199.00 Million ≈ $29.12 Million	CN¥3.57 Billion ≈ $522.87 Million	--

pp = percentage points

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$672.61 Million

CN¥4.60 Billion CNY

Market Cap Rank

#11094 Global

#3299 in China

Share Price

CN¥22.80

Change (1 day)

+2.10%

52-Week Range

CN¥21.90 - CN¥29.94

All Time High

CN¥221.47